News About: Pharm. Industry
Highly expected M&As were not able to reform the pharmaceutical industry
The prospect that gigantic M&Aswere going to be made in 2014 has escaped. Thus, M&As that can shake the pharmaceutical industry will move to the next year.
According to the industry concerned, listed pharmaceutical c...
The Celgene’s anticancer drug ‘Revlimid’ has the lowest margin, which created more financial damages to sellWhile the Korea Pharmaceutical Distribution Association is fighting a margin war with pharmaceutical companies, another low margin product has become an issue in the industry.
...
|
Pharmaceutical public-relation officers are making continuous promotions… the importance of communication has been raised
It has become a trend that pharmaceutical public-relation officers are promoting to board members. The trend grabbed the industry’s attention because it is not just a simple promotion, but a promotion to a board membe...
Due to conflicts between doctors and pharmacists over the generic substitution, pharmaceutical businessmen are the one suffering in-between
Conflicts between doctors and pharmacists over the generic substitution are causing hardship on blameless pharmaceutical businessmen.
Especially, businessmen dealing with clinic-level medical institutions are having ...
Large-selling pharmaceutical products will be expired in 2015
As the pharmaceutical industry has focused on patent-expiring pharmaceutical products due to the Patent Linkage System, which will be enforced soon, it is known that blockbuster-level pharmaceutical products are expec...
Boryung Pharmaceutical and Roche will co-promote the hepatitis type B and C treatment ‘Pegasys’
Boryung Pharmaceutical and Roche Korea will co-promote the chronic hepatitis type B and C treatment ‘Pegasys’.
Boryung Pharmaceutical (CEO Tae-hong Choi) and Roche Korea (General Manager Mike Crichton) announced on t...
The four-strain seasonal influenza vaccine ‘Fluarix Tetra’ is approved for the first time in Korea
The Ministry of Food and Drug Safety approved sales of the GSK’s four-strain influenza vaccine ‘Fluarix Tetra’ for the first time in Korea. It is expected that its launch will be made in the second half of the next ye...
Quintiles had the most clinical study approvals with 31 cases this year
It is known that the number of clinical studies, which the Ministry of Food and Drug Safety approved in 2014, was 667 in total.
Especially, since there are a lot of approvals passing through Contract Research Organiz...
SK Chemical is approved on the ‘Cell Culture-type Flu Vaccine’ for the first time in Korea and the third time internationally
SK Chemical (executive director and CEO Man-hoon Park) announced that the company acquired a product license for the first cell culture-type flu vaccine ‘skyCellflu’ in Korea from the Ministry of Food and Drug Safety ...
10 domestic pharmaceutical companies won against the patent nullity trial of ‘Crestor’
10 domestic pharmaceutical companies won on the composite patent nullity trial of the hyperlipidemia treatment ‘Crestor’.
Thus, they have set a stable foundation to sell generic products of Crestor, which launched on...
